INTERFERONS AND BONE - A COMPARISON OF THE EFFECTS OF INTERFERON-ALPHA AND INTERFERON-GAMMA IN CULTURES OF HUMAN BONE-DERIVED CELLS AND AN OSTEOSARCOMA CELL-LINE

Recombinant human interferon‐α2C and recombinant human interferon‐γ(5–1000 U/ml) inhibit the proliferation of normal human bone‐derived cells and a human osteosarcoma cell line. In the bone‐derived cells the inhibitory effect of interferon‐γ was significantly greater than that of interferon‐α, whereas in the osteosarcoma cell line the inhibitory effects of both interferons were quantitatively similar. Interferon‐α did not affect the alkaline phosphatase activity of either type of cells. In contrast, interferon‐γ affected the activity of the enzyme in both cell types: in the bone‐derived cells the effect of interferon‐γ was stimulatory whereas in the osteosarcoma cells the effect was inhibitory. In both cell types interferon‐γ selectively inhibited the incorporation of radiolabelled proline into type I collagen. In the osteosarcoma cells, the effects of both interferons on collagen synthesis were quantitatively similar. In the bone‐derived cells, however, interferon‐α decreased proline incorporation into collagen and non‐collagen proteins to a similar extent and thus did not affect collagen synthesis when expressed as a percentage of total protein synthesis. Two‐dimensional polyacrylamide gel electrophoresis of the radiolabelled proteins of the cell layer synthesised by both cell types in the presence of either interferon demonstrated that this treatment enhanced or induced the synthesis of a total of 21 individual proteins (19 in bone cells, 14 in osteosarcoma), ranging in apparent molecular mass over 14–87 kDa. The set of proteins induced was different in all four combinations of cells and interferon. A tentative identification of several of the proteins was possible based upon estimation of molecular mass, preferential induction by interferon‐α or interferon‐γ and differential induction in normal and transformed bone‐derived cells. The results of this study demonstrate that interferons have complex effects upon the proliferative and biosynthetic activities of human bone‐derived cells and demonstrate significant differences between the responses of normal cells and transformed bone‐derived cell line. Further investigations will be required in order to determine whether or not these differences are unique to the osteosarcoma cell line or are a characteristic of the effects of interferons on bone‐derived cells in general. Copyright © 1990, Wiley Blackwell. All rights reserved